All In Biotech

NDA 021855 · Bionpharma

Loperamide Hydrochloride

Loperamide Hydrochloride · Oral

Last checked: Nov 20, 2026Latest source record: Jun 22, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2005

Aug 4, 2005

Approved uses

1

Original approval plus efficacy supplements

Registered trials

97

20 Phase 3, 11 recruiting

FAERS reports

21,332

11,546 serious, 1,898 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 20, 2026.

Use controls symptoms of diarrhea, including Travelers' Diarrhea

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

2 products under this application
  • LOPERAMIDE HYDROCHLORIDE · LOPERAMIDE HYDROCHLORIDE 2MG · CAPSULE, ORAL · Over-the-counter
  • LOPERAMIDE HYDROCHLORIDE · LOPERAMIDE HYDROCHLORIDE 1MG · CAPSULE, ORAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Loperamide" as an intervention, any sponsor and status, largest first.

All 97 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • diarrhoea3,097
  • drug ineffective2,386
  • nausea1,565
  • fatigue1,511
  • off label use1,455
  • intentional product use issue977
  • constipation971
  • vomiting911
  • incorrect dose administered877
  • dyspnoea809
  • headache801
  • weight decreased723

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004319
2005232
2006160
2007323
2008372
2009330
2010209
2011401
2012355
2013222
2014254
20151,717
2016934
20171,665
20181,395
20191,505
20201,251
20211,039
20221,514
20231,824
20241,937
20251,922
20261,452

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 306 on PubMed

Sponsor: Bionpharma

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.